Medindia

X

FDA approves surgical gel

by Medindia Content Team on  November 21, 2001 at 12:47 PM General Health News   - G J E 4
FDA approves surgical gel
The Food and Drug Administration (FDA) approved a gel that promises less internal scarring for women undergoing certain surgeries. The FDA had initially rejected Lifecore Biomedical Inc.'s Intergel, which promises to reduce internal scarring from certain gynecologic operations.
Advertisement

The gel, formally named Gynecare Intergel Adhesion Prevention Solution, is intended to reduce adhesions, internal scar tissue that can cause chronic pain or intestinal obstruction. Various adhesion-preventing treatments already are sold, but Intergel is the first liquid one.

Advertisement
It is only for use during open gynecologic operations -- not the increasingly common "keyhole" surgeries where doctors operate through a small incision, the FDA warned. Nor is it for women with abdominal or pelvic infection, or who have cancer or are pregnant. The manufacturers would begin selling Intergel in February and cost about $200.

Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All